Sitagliptin phosphate monohydrate
Sitagliptin phosphate monohydrate Basic information
- Product Name:
- Sitagliptin phosphate monohydrate
- Synonyms:
-
- Sitagliptin monohydrate
- Sitagliptin Phosphate.H2O
- Sitagliptin Monophosphate Monohydrate
- (R)-3-AMino-1-(3-(trifluoroMethyl)-5,6-dihydro-[1,2,4]triazolo[4,3-a]pyrazin-7(8H)-yl)-4-(2,4,5-trifluorophenyl)butan-1-one phosphate hydrate
- Sitaglipin Phosphate Monohydrate
- (R)-3-amino-1-(3-(trifluoromethyl)-5,6-dihydro-[1,2,4]triazolo[4,3-a]pyrazin-7(8H)-yl)-4-(2,4,5-trifluorophenyl)butan-1-one phosphate monohydrate
- (R)-3-Amino-1-(3-(trifluor
- Sitagliptin posphate monohydrate
- CAS:
- 654671-77-9
- MF:
- C16H18F6N5O5P
- MW:
- 505.31
- EINECS:
- 682-492-2
- Product Categories:
-
- Inhibitors
- Inhibitor
- API
- APIs
- 654671-77-9
- Mol File:
- 654671-77-9.mol
Sitagliptin phosphate monohydrate Chemical Properties
- Flash point:
- 274.3℃
- storage temp.
- 2-8°C
- solubility
- ≥23.8 mg/mL in DMSO; insoluble in EtOH; ≥30.6 mg/mL in H2O with ultrasonic
- form
- solid
- color
- White to off-white
- InChI
- InChI=1/C16H15F6N5O.H3O4P/c17-10-6-12(19)11(18)4-8(10)3-9(23)5-14(28)26-1-2-27-13(7-26)24-25-15(27)16(20,21)22;1-5(2,3)4/h4,6,9H,1-3,5,7,23H2;(H3,1,2,3,4)/t9-;/s3
- InChIKey
- IQFYVLUXQXSJJN-OVMXBOEKNA-N
- SMILES
- P(O)(O)(O)=O.C(C1=NN=C2CN(C(=O)C[C@H](N)CC3C=C(F)C(F)=CC=3F)CCN12)(F)(F)F |&1:15,r|
- CAS DataBase Reference
- 654671-77-9(CAS DataBase Reference)
Safety Information
- Risk Statements
- 28-38-41-48-62-63
- Safety Statements
- 24/25-26-28-36/37/39
- HS Code
- 29335990
Sitagliptin phosphate monohydrate Usage And Synthesis
Chemical Properties
white crystalline
Uses
antimuscarinic
Uses
Sitagliptin Phosphate Monohydrate is a dipeptidyl peptidase-IV (DPPIV) inhibitor.
Biological Activity
sitagliptin phosphate monohydrate is the phosphate salt of its active component, sitagliptin, with one molecule of water. sitagliptin is a potent inhibitor of dipeptidyl peptidase 4 (dpp-4), an enzyme catalyzing the cleavage of peptides with an n-terminal alanine or proline amino acid residue, that selectively inhibits dpp-4 with 50% inhibition concentration ic50 value of 18 nm and shows no affinity towards other ddp enzymes (such as ddp-8 and ddp-9). the inhibition of dpp4 by sitagliptin has been found to be mediated by increasing levels of two dpp-4 substrates, including glucagon-like peptide-1 (glp-1) and gastric inhibitory polypeptide (gip). sitagliptin is currently being investigated in the treatment of type ii diabetes.gallwitz b. review of sitagliptin phosphate: a novel treatment for type 2 diabetes. vasc health risk manag. 2007;3(2):203-10.
target
DPP-4
Sitagliptin phosphate monohydrateSupplier
- Tel
- 0551-65523315 17705606359
- errol@homesunshinepharma.com
- Tel
- 0519-82813797 18994752886
- czkangte@hotmail.com
- Tel
- 0576-88808091 13958565781
- shuang.lin@zhenleichem.com
- Tel
- 0556-5800026 17709662922
- melrose@worldpharma.cn
- Tel
- 010-68862197 13810598707
- sales@huikangchem.com
Sitagliptin phosphate monohydrate(654671-77-9)Related Product Information
- tert-Butylchlorodiphenylsilane
- Dibutyl phthalate
- N,N-Dimethyl-1,4-phenylenediamine
- Sodium Phosphate Monobasic Monohydrate
- Glycine
- Buprofezin
- 2-Methyl-1-propanol
- Betamethasone 21-phosphate disodium
- 2-Butoxyethanol
- Calcium phosphate
- AMPHISOL A
- butyl rubber
- tert-Butyldimethylsilyl chloride
- BUTYL OLEATE
- MELIBIOSE
- Oseltamivir phosphate
- Tributyl phosphate
- tert-Butyl methyl ether